Seagen Inc. (SGEN) SEC Filing 8-K Material Event for the period ending Sunday, July 11, 2021

Seattle Genetics Inc Wa

CIK: 1060736 Ticker: SGEN

View differences made from one to another to evaluate Seattle Genetics Inc Wa's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Seattle Genetics Inc Wa.


Assess how Seattle Genetics Inc Wa's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Seattle Genetics Inc Wa's Definitive Proxy Statement (Form DEF 14A) filed after their 2021 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors



Financial Statements, Disclosures and Schedules

Inside this 8-K Corporate News

Ticker: SGEN
CIK: 1060736
Form Type: 8-K Corporate News
Accession Number: 0001193125-21-216418
Submitted to the SEC: Thu Jul 15 2021 4:23:06 PM EST
Accepted by the SEC: Thu Jul 15 2021
Period: Sunday, July 11, 2021
Industry: Biological Products No Disgnostic Substances
  1. New Agreement

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: